Dr Carolyn Shembrey
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
12 Scholarly works
5 Projects
HIGHLIGHTS
2024
Journal article
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision
DOI: 10.1126/sciadv.adl07312023
Journal article
A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients
DOI: 10.3389/fimmu.2022.10112472022
Journal article
NKG7 Enhances CD8 T Cell Synapse Efficiency to Limit Inflammation
DOI: 10.3389/fimmu.2022.9316302022
Research grants (other domestic)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Journal article
Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models
DOI: 10.3390/cancers140305812021
Journal article
Phenotypic consequences of slc25a40-abcb1 fusions beyond drug resistance in high-grade serous ovarian cancer
DOI: 10.3390/cancers13225644
RECENT SCHOLARLY WORKS
2021
Journal article
Serine biosynthesis is a metabolic vulnerability in flt3-itd–driven acute myeloid leukemia
DOI: 10.1158/2159-8290.CD-20-07382020
Conference Proceedings
REPROGRAMMING OF SERINE METABOLISM IS A METABOLIC VULNERABILITY IN FMS-LIKE TYROSINE KINASE 3 (FLT3) MUTANT ACUTE MYELOID LEUKAEMIA
DOI: 10.1016/j.exphem.2020.09.0242020
Journal article
Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer
DOI: 10.1016/j.canlet.2020.02.0262019
Journal article
Impact of tumor and immunological heterogeneity on the anti-cancer immune response
DOI: 10.3390/cancers110912172018
Conference Proceedings
Optical barcoding highlights novel characteristics of treatment resistant cells in metastatic colorectal cancer
RECENT PROJECTS
2022
Internal Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13